General Information of Drug (ID: DMXWUHA)

Drug Name
Ribostamycin Drug Info
Synonyms
ribostamycin; Vistamycin; Hetangmycin; Xylostatin; Antibiotic SF 733; Ribostamycinum; Ribostamicina; Ribostamycine; Ribastamin; Dekamycin IV; SF 733; 25546-65-0; ribostamycin A; Ribostamycin [INN:BAN]; Bu 1709; Ribostamycine [INN-French]; Ribostamycinum [INN-Latin]; UNII-2Q5JOU7T53; SF-733; Ribostamicina [INN-Spanish]; C17H34N4O10; EINECS 247-091-5; NSC 138925; BRN 1357280; 2Q5JOU7T53; CHEBI:45257; NSC138925; O-2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1->4)-O-(beta-D-ribofuranosyl-(1->5))-2-deoxystreptamine
Cross-matching ID
PubChem CID
33042
ChEBI ID
CHEMBL45257
CAS Number
CAS 25546-65-0
TTD Drug ID
D08PVY

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Proximal tubule bicarbonate reclamation 1.78 2.15e-1 21/23 (91.3%) CA2;SLC4A4;PCK2;...
Neomycin, kanamycin and gentamicin biosynthesis 1.68 2.04e-1 5/5 (100%) HK2;HK3;HK1
Melanogenesis 1.67 1.72e-1 74/101 (73.27%) PLCB1;LEF1;EDNRB;...
Fatty acid elongation 1.63 2.17e-1 19/27 (70.37%) HACD1;HACD3;PPT2;...
Biosynthesis of unsaturated fatty acids 1.61 2.10e-1 21/27 (77.78%) HACD1;HACD3;SCD5;...
Gastric acid secretion 1.61 1.86e-1 63/76 (82.89%) CA2;PLCB1;KCNJ16;...
Cell cycle 1.59 2.20e-1 110/124 (88.71%) SMC1A;CCNB2;ABL1;...
Collecting duct acid secretion 1.57 2.33e-1 22/27 (81.48%) CA2;ATP6V1D;SLC4A1
Oocyte meiosis 1.56 2.20e-1 90/129 (69.77%) SMC1A;CCNB2;PPP2R1B;...
African trypanosomiasis 1.56 2.18e-1 32/37 (86.49%) PLCB1;APOA1;PRKCA;...
T cell receptor signaling pathway 1.54 2.43e-1 93/104 (89.42%) NCK1;NFATC3;CDC42;...
Glycolysis / Gluconeogenesis 1.53 2.24e-1 56/67 (83.58%) ENO2;FBP1;PCK2;...
Adherens junction 1.53 2.20e-1 63/71 (88.73%) CDC42;TJP1;LEF1;...
Cholesterol metabolism 1.53 2.06e-1 44/50 (88%) APOA2;APOA1;APOB;...
Focal adhesion 1.50 2.40e-1 180/201 (89.55%) CDC42;FN1;COL4A5;...
ABC transporters 1.49 2.50e-1 37/45 (82.22%) ABCC4;ABCG2;ABCA3;...
Endocrine and other factor-regulated calcium reabsorpti... 1.48 2.47e-1 49/53 (92.45%) PLCB1;PRKCA;FXYD2;...
Pancreatic secretion 1.46 2.79e-1 87/102 (85.29%) CA2;PLCB1;SLC4A4;...
Arrhythmogenic right ventricular cardiomyopathy 1.46 2.77e-1 70/77 (90.91%) GJA1;LEF1;DMD;...
Proteasome 1.46 2.71e-1 44/46 (95.65%) PSMD6;PSMB5;PSMA1;...
Hypertrophic cardiomyopathy 1.46 2.59e-1 81/90 (90%) TTN;DMD;TNNC1;...
Adrenergic signaling in cardiomyocytes 1.45 2.50e-1 130/150 (86.67%) PLCB1;TNNC1;PPP2R1B;...
Thyroid hormone synthesis 1.45 2.45e-1 66/75 (88%) PLCB1;ALB;PRKCA;...
Dilated cardiomyopathy 1.45 2.44e-1 86/96 (89.58%) TTN;DMD;TNNC1;...
Pentose phosphate pathway 1.44 2.37e-1 25/30 (83.33%) FBP1;PGD;G6PD;...
Wnt signaling pathway 1.43 2.56e-1 124/166 (74.7%) PLCB1;NFATC3;SFRP1;...
Protein digestion and absorption 1.43 2.49e-1 78/103 (75.73%) COL5A2;COL4A5;COL6A3;...
Starch and sucrose metabolism 1.42 2.70e-1 25/36 (69.44%) MGAM;HK2;GBE1;...
Complement and coagulation cascades 1.41 2.77e-1 76/85 (89.41%) SERPINA1;FGG;C5;...
Amoebiasis 1.40 2.88e-1 99/102 (97.06%) PLCB1;FN1;COL4A5;...
Cocaine addiction -1.08 9.02e-1 42/49 (85.71%) DDC;JUN;ATF2;...
Glycerophospholipid metabolism -1.11 8.89e-1 71/98 (72.45%) PLPP2;PEMT;ETNPPL;...
Antigen processing and presentation -1.14 8.49e-1 60/78 (76.92%) HLA-DPA1;HLA-E;HLA-F;...
Transcriptional misregulation in cancer -1.14 8.71e-1 158/192 (82.29%) KLF3;CDKN2C;NR4A3;...
Glioma -1.14 8.98e-1 67/75 (89.33%) PDGFRB;PTEN;IGF1;...
Breast cancer -1.15 9.01e-1 119/147 (80.95%) NRAS;FGF20;PIK3CA;...
Olfactory transduction -1.16 8.52e-1 69/440 (15.68%) OR2B2;OR2H2;OR12D3;...
p53 signaling pathway -1.17 8.39e-1 63/73 (86.3%) CCNG1;CDK1;SFN;...
Type I diabetes mellitus -1.17 8.58e-1 38/43 (88.37%) IL1B;HLA-DPA1;HLA-E;...
Acute myeloid leukemia -1.19 8.16e-1 66/67 (98.51%) STAT5B;RUNX1T1;MYC;...
Fatty acid biosynthesis -1.19 8.44e-1 16/18 (88.89%) ACSBG2;ACSL6;ACACB;...
Mannose type O-glycan biosynthesis -1.19 8.73e-1 14/23 (60.87%) B4GALT3;B4GALT1;FUT9;...
Nucleotide excision repair -1.19 8.81e-1 40/47 (85.11%) ERCC1;POLD4;GTF2H3;...
Lysosome -1.23 8.83e-1 115/128 (89.84%) NAGLU;AP1B1;SMPD1;...
Regulation of lipolysis in adipocytes -1.26 7.55e-1 52/55 (94.55%) LIPE;CGA;GNAS;...
Arachidonic acid metabolism -1.27 7.70e-1 48/61 (78.69%) PLA2G5;PTGDS;CBR3;...
Melanoma -1.27 7.98e-1 68/72 (94.44%) PDGFRB;PTEN;IGF1;...
Bladder cancer -1.29 7.50e-1 40/41 (97.56%) MYC;VEGFA;CDK4;...
Prostate cancer -1.29 8.04e-1 93/97 (95.88%) PDGFRB;NFKB1;PTEN;...
Metabolism of xenobiotics by cytochrome P450 -1.31 7.71e-1 49/77 (63.64%) CBR3;SULT2A1;CYP2F1;...
Systemic lupus erythematosus -1.33 7.31e-1 45/135 (33.33%) C1R;HLA-DQB1;C1S;...
Ribosome -1.33 7.84e-1 113/158 (71.52%) MRPS14;RPL36A;RPL24;...
Caffeine metabolism -1.34 8.21e-1 5/6 (83.33%) XDH;NAT2;NAT1;...
Retinol metabolism -1.36 8.25e-1 41/68 (60.29%) CYP26B1;ADH1B;UGT2B17;...
Phosphonate and phosphinate metabolism -1.41 7.29e-1 5/6 (83.33%) CEPT1;CHPT1
Other glycan degradation -1.43 7.62e-1 13/18 (72.22%) MANBA;HEXB;FUCA1;...
alpha-Linolenic acid metabolism -1.49 6.17e-1 17/25 (68%) PLA2G4C;PLA2G1B;PLA2G5;...
Linoleic acid metabolism -1.50 7.69e-1 21/29 (72.41%) PLA2G4C;ALOX15;PLA2G1B;...
Aminoacyl-tRNA biosynthesis -1.58 6.35e-1 15/66 (22.73%) GATB;NARS2;HARS2;...
Chronic myeloid leukemia -1.64 7.07e-1 72/76 (94.74%) STAT5B;MYC;BAD;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H